T. Parent

Suggest Changes
Learn More
7044 Background: Concurrent chemoradiotherapy (CRT) is a curative potential treatment for unresectable stage III NSCLC, yet the optimal treatment paradigm and choice of regimen is unclear. Previous(More)
  • 1